HIMS Hims & Hers Health, Inc.
Healthcare$23.85+0.42%ClosedMarket Cap: $5.24B
As of 2026-05-26
Valuation
P/E (TTM)
33.23
PEG
18.00
P/B
12.16
P/S
2.20
EV/EBITDA
61.34
DCF Value
$112.69
FCF Yield
1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.6%
Operating Margin
1.3%
Net Margin
-0.6%
ROE
-2.5%
ROA
-0.6%
ROIC
0.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $608.1M | 49.4% | $-16.5M | $-92.1M | $— | — |
| Q4 null | $617.8M | 71.9% | $9.2M | $20.6M | $— | — |
| FY null | $2.35B | 73.8% | $105.6M | $128.4M | $— | — |
| Q3 null | $599.0M | 73.8% | $11.8M | $15.8M | $— | — |
| Q2 null | $544.8M | 76.4% | $26.7M | $42.5M | $— | — |
| Q1 null | $586.0M | 73.5% | $57.9M | $49.5M | $— | — |
| Q4 null | $481.1M | 76.8% | $18.6M | $26.0M | $— | — |
| FY null | $1.48B | 79.5% | $61.9M | $126.0M | $— | — |
| Q3 null | $401.6M | 79.2% | $22.4M | $75.6M | $— | — |
| Q2 null | $315.6M | 81.3% | $11.0M | $13.3M | $— | — |
| Q1 null | $278.2M | 82.4% | $9.9M | $11.1M | $— | — |
| Q4 2023 | $246.6M | 82.7% | $-400.0K | $1.2M | $0.01 | — |